Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Dapagliflozin on the Apoptosis Levels of Patients With Acute Myocardial Infarction - DAPOPTOSIS-MI (a Randomized Controlled Trial)

NCT06615674 is registered in ClinicalTrials.gov with Yoga Yudhistira as lead sponsor.

NCT NCT06615674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06615674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Dapagliflozin on the Apoptosis Levels of Patients With Acute Myocardial Infarction - DAPOPTOSIS-MI (a Randomized Controlled Trial)
Lead sponsor
Yoga Yudhistira
Phase
Phase 4
Overall status
Completed
Start date
September 21, 2024
Completion date
December 7, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami), nstemi - non-st segment elevation myocardial infarction (mi), stemi - st elevation myocardial infarction (mi)